Journey Medical Corporation
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Journey Medical Corporation sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Journey Medical Corporation: 9 sponsored US clinical trials, none currently recruiting.
Journey Medical Corporation sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 5 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Papulopustular Rosacea, with 2 trials.
Top-decile sponsor footprint
Journey Medical Corporation ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
NCT05597462
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
NCT05343455
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
NCT05296629
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
NCT03880266
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis
NCT02530294
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
NCT02553798
Study of Glycopyrronium in Axillary Hyperhydrosis
NCT02530281
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
NCT02129660
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
NCT02016885
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 5 |
Therapeutic Areas
How the Journey Medical Corporation archive is shaped
9 indexed studies, none listed as recruiting (0% open); 9 completed (100%).
Phase mix: 5 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Papulopustular Rosacea (2 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Journey Medical Corporation: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Journey Medical Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Journey Medical Corporation page
9 registered trials is a research-attention snapshot, not an endorsement of Journey Medical Corporation or any single study.
- None of Journey Medical Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Papulopustular Rosacea is the condition Journey Medical Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Papulopustular Rosacea trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Journey Medical Corporation pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.